Delivery Order SPE2DB22D1106-SPE2DB24FDYV8

Award Date 2/6/24
Potential Completion Date 2/28/24
Potential Value $6K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award from the Medical Supply Chain division of the Defense Logistics Agency (DLA) was issued to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The $11,053.26 firm fixed price delivery order is for the pharmaceutical product TRODELVY 180 MG VIALS, with a performance period through April 17, 2024. Amerisourcebergen Drug Corp holds an indefinite delivery contract (IDC) with DLA Troop Support Medical valued at up to $999,999,999.00 through December...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, Corporate Office Division, a subsidiary of the major pharmaceutical distributor Amerisourcebergen Corporation. The $6,007.00 firm-fixed price delivery order is for the supply of TRODELVY 180 MG VIALS, a prescription medication. This award is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 that Amerisourcebergen holds with DLA Troop Support Medical to...
This federal contract award, valued at $9,010.50, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. The award is a firm fixed price delivery order for the pharmaceutical product TRODELVY 180MG VIAL 1S, with a period of performance through April 8, 2024. Amerisourcebergen Drug Corp holds a larger indefinite delivery contract (IDC) valued up to...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The $9,010.50 firm fixed price delivery order is for the supply of TRODELVY 180 MG VIALS, a specialty pharmaceutical product, to support military treatment programs and facilities. Amerisourcebergen Drug Corp holds an indefinite delivery contract...
This federal contract award was made by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $15,536.60 firm fixed-price delivery order is for the provision of TRODELVY 180 MG vials, a specialty medication. This contract is under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical, running through November...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation's Corporate Office Division. The award, valued at $6,007.00, is for the provision of 180 mg vials of the pharmaceutical drug TRODELVY. This is a firm fixed-price contract with a period of performance ending on July 24, 2024. The contract does not have a set-aside designation. AmerisourceBergen, a major pharmaceutical distribution company, is the prime contractor for this award. The...
This is a federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The $9,010.50 Firm Fixed Price Delivery Order is for the supply of the pharmaceutical product TRODELVY 180MG VIAL 1S, with a period of performance through May 9, 2024. Amerisourcebergen holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as the primary...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office Division. The $3,003.50 firm fixed price delivery order is for the provision of TRODELVY 180 MG VIALS, a pharmaceutical product. The contract has a period of performance through July 3, 2024 and does not have a set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distribution company, holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA...
This federal contract award, valued at $12,779.44, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order with a firm fixed price pricing type, intended to supply the product "TRODELVY 180 MG VIALS" to support federal healthcare programs. The contract has an ultimate completion date of March 24, 2025. Amerisourcebergen also holds a $999,999,999 Indefinite...
This federal contract award is for the delivery of TRODELVY 180 MG VIALS to the Defense Logistics Agency (DLA), a defense agency. The contract, valued at $6,389.72, was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a firm fixed price pricing type and an ultimate completion date of February 12, 2025. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
  • SPE2DB22D1106
    Indefinite Delivery Contract
  • SPE2DB22D1106-SPE2DB24FDYV8
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical company Amerisourcebergen Corporation. The $6,007.00 firm fixed price delivery order is for the supply of TRODELVY 180 MG VIALS, a specialty pharmaceutical product, with a performance period ending on February 28, 2024.

Amerisourcebergen Drug Corp holds an indefinite delivery contract (IDC) with DLA, valued at up to $999,999,999.00 through December 31, 2025, which serves as the primary vehicle for the company to provide pharmaceutical products and medical supplies to DLA Troop Support Medical facilities supporting the Department of Defense. This award is not associated with any set-aside designation. Amerisourcebergen Drug Corp is the sole awardee on this IDC contract, which enables the company to deliver a comprehensive range of medications and healthcare materials to military treatment programs and medical facilities worldwide.

Generated 5/7/24, 11:57 AM